The mortality rate from Chronic Liver Diseases and Cirrhosis in the US is on a steady upward trend from the 2023 baseline. The projected data from 2024 to 2028 shows an average Compound Annual Growth Rate (CAGR) of approximately 4.6%. Year-on-year growth is consistent, ranging between 4% and 5%, indicating a persistent increase in mortality rates. This climbing trend reflects worsening health outcomes potentially linked to lifestyle factors and broader health system issues.
Future trends to watch for include:
- The impact of new medical treatments and interventions on liver disease management.
- Public health campaigns targeting liver disease prevention and lifestyle modifications.
- Socioeconomic factors influencing access to healthcare and treatment adherence.
- Advancements in liver disease biomarkers and early detection technologies.
